NCT00362440 Combination of Insulin Sensitizer and Leptin as Treatment for the HAART -Induced Metabolic Syndrome Status COMPLETED Phase PHASE2
NCT00361244 SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00361231 Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder Cancer Status COMPLETED Phase PHASE2
NCT00328094 Glycemic Control to Prevent Cardiac Morbidity in Vascular Surgery Status TERMINATED Phase NA
NCT00321646 Neoadjuvant Bevacizumab Plus Docetaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy Status COMPLETED Phase PHASE2
NCT00307736 Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00307723 Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00305097 Effects of Caffeinated and Decaffeinated Coffee on Body Weight and Glucose Tolerance Status COMPLETED Phase NA
NCT00301093 Vaccine Therapy and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Status COMPLETED Phase PHASE1